BlackRock reports 8.1% stake in Ironwood
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock, Inc. reports beneficial ownership of Class A stock of Ironwood Pharmaceuticals Inc on an amended Schedule 13G (Amendment No. 6). BlackRock and certain of its business units collectively beneficially own 13,373,568 shares, representing 8.1% of Ironwood’s outstanding Class A stock.
BlackRock has sole voting power over 13,195,313 shares and sole dispositive power over all 13,373,568 shares, with no shared voting or dispositive power reported. Various underlying clients and accounts have rights to dividends or sale proceeds, but no single person’s interest exceeds five percent of Ironwood’s outstanding common shares.
Key Figures
Key Terms
beneficially owned financial
Sole Voting Power financial
Sole Dispositive Power financial
parent holding company financial
Power of Attorney regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of IRWD Class A stock does BlackRock, Inc. report owning?
Whose holdings are reported in BlackRock’s Schedule 13G/A for IRWD?
AI-generated analysis. How Rhea-AI works. Not financial advice.